The AACR Virtual Annual Meeting Session I will take place April 10-15. Please visit https://www.abstractsonline.com/pp8/#!/9325 for more information. The Virtual Annual Meeting Session II takes place May 17-21. Please check back for information on Session II talks.
A number of CCR scientists will present their research at the AACR Annual Meeting. Selected oral presentations are listed below.
Friday, April 9, 2021
| Time | Where to View | Title | Presenter/Authors | Session |
|---|---|---|---|---|
| 12:05 AM - 12:05 AM | On Demand | From oxygen sensing to nutrient and energy sensing: Targeting the genetic basis of renal cell carcinoma | Marston Linehan, M.D., Urologic Oncology Branch |
Session SS06.OD - AACR-ASCO Joint Session: Targets in the Treatment of Renal Cell Cancer |
| 12:05 AM - 11:59 PM | On Demand | How nonalcoholic fatty liver disease affects antitumor immunity in HCC | Tim F. Greten, M.D., Thoracic and GI Malignancies Branch |
Session AOS07.OD - Emerging Concepts in Liver Cancer Research |
| 12:05 AM - 11:59 PM | On Demand | Understanding tumor cell clonality and Its evolution by single-cell transcriptomics in liver cancer | Xin Wei Wang, Ph.D., Laboratory of Human Carcinogenesis |
Session AOS07.OD - Emerging Concepts in Liver Cancer Research |
| 12:05 AM - 11:59 PM | On Demand | Tumor in the crossfire: Targeting PD-L1 and TGF-β with bintrafusp alfa | James L. Gulley, M.D., Ph.D., Genitourinary Malignancies Branch | Session SY19.OD - When Is Transforming Growth Factor Beta Targetable? |
| 12:05 AM - 11:59 PM | On Demand | Near-infrared photoimmunotherapy for cancers: A new theranostic technology | Hisataka Kobayashi, M.D., Ph.D., Molecular Imaging Branch | Session ADT05.OD - Hybrid Technologies for Cancer Imaging, Theranostics, and Image-Guided Interventions |
Saturday, April 10, 2021
| Time | Where to View | Title | Presenter/Authors | Session |
|---|---|---|---|---|
| 4:05 PM - 4:15 PM | Channel 03 | Single cell mapping of tumor infiltrating lymphocytes enables neoantigen-reactive T cell identification in metastatic human cancer | Frank J. Lowery III, Ph.D., Surgery Branch |
Session MS.TB06.01 - Redefining the Tumor Microenvironmental Vulnerability with Single Cell Technologies |
| 4:05 PM - 4:15 PM | Channel 04 | The recently approved high-TMB criteria may introduce a sex bias in response to PD1 inhibitors | Neelam Sinha, MSc., Cancer Data Science Laboratory |
Session MS.EP01.01 - Identifying Disparities and Underserved Populations to Influence Personalized Medicine |
| 5:20 PM - 5:30 PM | Channel 04 | High urinary thromboxane B2 associates with lethal prostate cancer in African American men and inversely correlates with aspirin use | Maeve Bailey-Whyte, Ph.D., Laboratory of Human Carcinogenesis | Session MS.EP01.01 - Identifying Disparities and Underserved Populations to Influence Personalized Medicine |
| 5:20 PM - 5:30 PM | Channel 05 | Immune cell transcriptomic signatures in different cancer types markedly diverge from their corresponding signatures in the peripheral blood | Fiorella Schischlik, Ph.D., Cancer Data Science Laboratory |
Session MS.BSB02.01 - Integrative Data Analysis and Systems Modeling |
Sunday, April 11, 2021
| Time | Where to View | Title | Presenter/Authors | Session |
|---|---|---|---|---|
| 2:50 PM - 3:00 PM | Channel 06 | Identification of first-in-class KDM3B inhibitors that suppress PAX3-FOXO1 oncogene activity in fusion positive rhabdomyosarcoma | Yong Yean Kim, M.D., Ph.D., Genetics Branch |
Session MS.ET06.01 - New Therapeutics Targeting Molecular Drivers in Cancer |
| 3:05 PM - 3:15 PM | Channel 03 | Activating mucosal-associated invariant T cells (MAITs) induces a broad anti-tumor response and offers a novel target for cancer immunotherapy | Benjamin Ruf, M.D., Thoracic and GI Malignancies Branch |
Session MS.IM01.01 - Mapping the Cellular and Molecular Cues That Control Therapeutic Antitumor Immunity |
Monday, April 12, 2021
| Time | Where to View | Title | Presenter/Authors | Session |
|---|---|---|---|---|
| 10:00 AM - 10:30 AM | Channel 06 | Panel Discussion |
Tim F. Greten, M.D., Xin-Wei Wang, Ph.D., |
AOS07.DISC - Panel-- Emerging Concepts in Liver Cancer Research |
Tuesday, April 13, 2021
| Time | Where to View | Title | Presenter/Authors | Session |
|---|---|---|---|---|
| 2:30 PM - 3:00 PM | Channel 08 | Invited Speaker | Dinah S. Singer, Ph.D., Experimental Immunology Branch |
SS09 - Recent Progress and the Future of the Cancer Moonshot |
| 2:30 PM - 3:00 PM | Channel 02 | Panel Discussion | W. Marston Linehan, M.D. Urologic Oncology Branch |
SS06.DISC - Panel-- AACR-ASCO Joint Session: Targets in the Treatment of Renal Cell Cancer |
| 3:30 PM - 4:00 PM | Channel 03 | Panel Discussion | James L. Gulley, M.D., Ph.D. Genitourinary Malignancies Branch |
SY19.DISC - Panel-- When Is Transforming Growth Factor Beta Targetable? |
Wednesday, April 14, 2021
| Time | Where to View | Title | Presenter/Authors | Session |
|---|---|---|---|---|
| 1:30 PM - 2:00 PM | Channel 07 | Panel Discussion | Hisataka Kobayashi, M.D., Ph.D.
Molecular Imaging Branch
|
ADT05.DISC - Panel-- Hybrid Technologies for Cancer Imaging, Theranostics, and Image-Guided Interventions |